AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Becton, Dickinson and Company
Video analysis: BDX
All videosNo video analysis for this stock yet. Request one from our team.
News: BDX
Is BDX Overvalued? DCF Says Worth $157
On September 10, 2026, we delve into the DCF analysis for Becton Dickinson and Co (BDX), a company that has shown a year-to-date price increase of 20.1%. However,
Becton, Dickinson and Company (BDX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Becton, Dickinson and Company (BDX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
BDX DCF Analysis: Intrinsic Value $157 vs Price $187
On September 02, 2026, we delve into the DCF analysis for Becton Dickinson and Co (BDX), a company that has shown notable price performance with a year-to-date in
Two Recessions Couldn't Stop These 4 Healthcare Stocks From Raising Dividends
Two brutal recessions wiped out dividends across the market, yet a handful of healthcare companies kept raising their payouts through every quarter of both downturns.
Jim Cramer Calls This Mining Stock an Inflation Hedge “Just as Good as Crypto”
On a recent edition of CNBC's Mad Money Lightning Round, Jim Cramer fielded questions from viewers. Two of Cramer's clearest calls were to buy Vale (NYSE:VALE | VALE Price Prediction) as an inflation hedge comparable to cryptocurrency and to stay long Apple (NASDAQ:AAPL) through an upcoming leadership change.
BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation
STANCE trial surpasses a key enrollment milestone, advancing the clinical evaluation of GalaFLEX LITE™ Scaffold and generating evidence to support its use in breast revision surgery for capsular contracture FRANKLIN LAKES, N.J., Aug. 27, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a significant milestone in its advanced tissue regeneration strategy and expansion efforts with the STANCE clinical trial evaluating GalaFLEX LITE™ Scaffold in breast revision surgery for capsular contracture.
BD to Present at Wells Fargo 21st Annual Healthcare Conference
FRANKLIN LAKES, N.J., Aug. 26, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 9:30 a.m.
BDX DCF Analysis: Intrinsic Value $157 vs Price $190
On August 26, 2026, we conducted a DCF analysis for Becton Dickinson and Co (BDX), a company that has shown strong price performance recently with a 1-week increa
Similar companies
-
Edwards Lifesciences Corporation
EW
·
New York Stock Exchange
Compare
-
Cardinal Health, Inc.
CAH
·
New York Stock Exchange
Compare
-
argenx SE
ARGX
·
NASDAQ
Compare
-
Alcon Inc.
ALC
·
New York Stock Exchange
Compare
-
ResMed Inc.
RMD
·
New York Stock Exchange
Compare
-
Agilent Technologies, Inc.
A
·
New York Stock Exchange
Compare